Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4752 |  LGVN Longeveron Inc. - Class A Common stock | 2.37 USD | -2.87% | -7.42% | -63.65% | +315.79% | 7.56 M USD | ||
| 4755 |  CURX Curanex Pharmaceuticals Inc - Common Stock | 4.76 USD | -1.04% | +1.28% | +14.42% | +534.67% | 7.46 M USD | ||
| 4756 |  SKYE Skye Bioscience, Inc. - Common Stock | 1.68 USD | +1.82% | +2.44% | -23.64% | +110.00% | 7.44 M USD | ||
| 4759 |  FBLG FibroBiologics, Inc. - Common Stock | 1.11 USD | -2.63% | -7.50% | -35.84% | +126.53% | 7.39 M USD | ||
| 4760 |  TRAW Traws Pharma, Inc. - Common Stock | 0.48 USD | 0.00% | -14.29% | -11.11% | -84.42% | 7.38 M USD | ||
| 4765 |  INM InMed Pharmaceuticals Inc. - Common Shares | 1.33 USD | 0.00% | -2.92% | +1.53% | -43.40% | 7.31 M USD | ||
| 4766 |  APRE Aprea Therapeutics, Inc. - Common Stock | 0.56 USD | -8.20% | -22.22% | -28.21% | -62.67% | 7.05 M USD | ||
| 4767 |  BOLT Bolt Biotherapeutics, Inc. - Common Stock | 3.63 USD | +0.83% | +3.71% | -2.16% | -38.99% | 6.99 M USD | ||
| 4771 |  ENVB Enveric Biosciences, Inc. - Common Stock | 1.52 USD | +1.33% | +0.66% | +7.04% | -38.21% | 6.80 M USD | ||
| 4779 |  XCUR Exicure, Inc. - Common Stock | 1.01 USD | -0.98% | -13.68% | -28.37% | -82.59% | 6.61 M USD | ||
| 4780 |  ACXP Acurx Pharmaceuticals, Inc. - Common Stock | 1.25 USD | -3.85% | -2.34% | -11.35% | -34.90% | 6.59 M USD | ||
| 4782 |  ALZN Alzamend Neuro, Inc. - Common Stock | 1.34 USD | -2.19% | -0.74% | -19.76% | -41.99% | 6.47 M USD | ||
| 4794 |  NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 3.74 USD | -2.09% | -5.79% | +884.21% | +199.20% | 6.09 M USD | ||
| 4796 |  IMNN Imunon, Inc. - Common Stock | 1.07 USD | -4.46% | -20.74% | -35.54% | -67.08% | 6.00 M USD | ||
| 4803 |  KALA KALA BIO, Inc. - Common Stock | 0.30 USD | -16.67% | -26.83% | -46.43% | -80.52% | 5.80 M USD | ||
| 4808 |  CELZ Creative Medical Technology Holdings, Inc. - Common Stock | 0.86 USD | -2.27% | -6.52% | -18.10% | -75.29% | 5.67 M USD | ||
| 4812 |  PULM Pulmatrix, Inc. - Common Stock | 1.53 USD | +2.68% | -3.77% | +1.32% | -67.52% | 5.59 M USD | ||
| 4815 |  LEXX Lexaria Bioscience Corp. - Common Stock | 3.36 USD | -4.00% | +5.66% | -52.00% | +286.21% | 5.55 M USD | ||
| 4818 |  CDIO Cardio Diagnostics Holdings Inc. - Common stock | 1.86 USD | -5.58% | -5.58% | -7.92% | -29.01% | 5.50 M USD | ||
| 4820 |  AIM AIM ImmunoTech Inc. Common Stock | 0.18 USD | 0.00% | -5.26% | -18.18% | -93.21% | 5.48 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |